Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, and no standardized methods exist to estimate the prevalence of...
Saved in:
Main Authors: | Elizabeth Pisani (Author), Amalia Hasnida (Author), Mawaddati Rahmi (Author), Maarten Olivier Kok (Author), Steven Harsono (Author), Yusi Anggriani (Author) |
---|---|
Format: | Book |
Published: |
JMIR Publications,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019) -
Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020) -
Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020) -
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
by: Faris El-Dahiyat, et al.
Published: (2021)